Trial Profile

A phase 2, open-label, randomized, 2-way crossover, clinical trial to compare the pharmacokinetics of 2 formulations of 'intended commercial product' Technosphere insulin inhalation powder and to determine the bioavailability of a 30 unit cartridge of `intended commercial product' Technosphere insulin inhalation powder versus a 10 unit subcutaneous injection of insulin lispro in subjects with type 1 diabetes mellitus

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 21 Oct 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

27 Jun 2010 Results reported at Amercian Diabetes Association (ADA) meeting, according to a MannKind Corporation media release.
17 May 2008 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com